IP Library Granted Patent US 10,704,079
Granted Patent B2
US 10,704,079 · App. 15/905,422 · Granted Jul 7, 2020

Methods for the detection of beta-lactamases in a sample

Inventors: Mei Yang-Woytowitz (Baltimore, MD); Charles Yu (Lutherville, MD); Timothy Wiles (Manchester, MD)
Assignee: Becton, Dickinson and Company
C12Q1/34C12Q1/04G01N2333/986
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,704,079
App. No.
15/905,422
Granted
Jul 7, 2020
Kind
B2
Abstract

Presented herein are methods for the detection of specific beta-lactamases, including class A serine carbapenemases, metallo-beta-lactamases, AmpC beta-lactamases, and extended-spectrum beta-lactamases (ESBLs). The methods presented herein include methods that permit the detection of the presence of specific beta-lactamases in bacterial samples within as few as 2 to 10 minutes.

Claims (15)

1. A method for detecting the presence of a beta-lactamase in a sample, comprising:

(a) providing a solid support comprising a plurality of wells, the plurality of wells comprising:

i) a first well containing a dry composition comprising a lysis reagent, and

ii) a second well containing a dry composition comprising a beta-lactamase substrate;

(b) rehydrating the dry composition in the first and second well;

(c) contacting a bacterial sample with the composition in the first well;

(d) contacting the bacterial sample with the composition in the second well; and

(e) detecting utilization of the beta-lactamase substrate in the second well,

wherein utilization of the beta-lactamase substrate indicates the presence of a beta-lactamase.

2. The method of claim 1 , wherein the beta-lactamase substrate is an antibiotic.

3. The method of claim 1 , wherein the plurality of wells further comprise a third well containing a dry composition comprising a beta-lactamase substrate and one or more beta-lactamase inhibitors, and wherein the method further comprises:

(b)′ rehydrating the dry composition in the third well;

(d)′ contacting the bacterial sample with the composition in the third well; and

(e)′ detecting utilization of the beta-lactamase substrate in the third well,

wherein utilization of the beta-lactamase substrate in the third well indicates the presence of a beta-lactamase not inhibited by the one or more beta-lactamase inhibitors.

Continuity (6)
Continuation 14745722 · Jun 22, 2015
Division 13778767 · Feb 27, 2013
Division 13307426 · Nov 30, 2011
Division 12254594 · Oct 20, 2008
Provisional Application 60981156 · Oct 19, 2007
Related Publication 20180334701A1 · Nov 22, 2018